Skip to main content
. 2022 Jan 17;11:e68832. doi: 10.7554/eLife.68832

Appendix 1—figure 9. DeepPurpose-based target protein predictions.

Appendix 1—figure 9.

(A) Identification of predicted positive mediators of a positive insulin resistance-drug repurposing (IR-DR) score agrees with the pharmacological analysis. (B) Identification of predicted negatively acting proteins, diminishing the strength of a positive IR-DR score, or cancelling out any positive activity, agrees with and extends the known pharmacology.